• LAST PRICE
    0.7401
  • TODAY'S CHANGE (%)
    Trending Down-0.0098 (-1.3068%)
  • Bid / Lots
    0.7400/ 5
  • Ask / Lots
    0.7401/ 5
  • Open / Previous Close
    0.7500 / 0.7499
  • Day Range
    Low 0.7311
    High 0.7500
  • 52 Week Range
    Low 0.7201
    High 1.5600
  • Volume
    58,086
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 0.7499
TimeVolumeBOLT
09:32 ET11810.75
09:39 ET10000.745
09:41 ET1000.7455
09:45 ET1000.7416
09:48 ET1000.7493
10:06 ET9420.7416
10:08 ET17150.74
10:10 ET2000.74455
10:12 ET1000.7446
10:17 ET1000.74
10:35 ET11420.74
10:37 ET15000.740101
10:42 ET3000.7489
10:44 ET3000.7425
10:55 ET1000.7444
10:57 ET2000.7488
11:09 ET2000.7422
11:11 ET25680.74215
11:20 ET5620.735
11:27 ET4000.7379
11:33 ET1000.7311
11:36 ET1000.7311
11:40 ET1000.733
11:47 ET9190.733
11:49 ET4500.7331
11:54 ET8000.7311
11:56 ET7000.7315
12:00 ET7000.7318
12:02 ET2000.7317
12:03 ET4000.7319
12:05 ET17000.731951
12:09 ET5000.731951
12:16 ET13530.7324
12:18 ET18470.7331
12:21 ET4900.7411
12:25 ET1000.7366
12:32 ET7500.7366
12:38 ET1000.7371
12:54 ET4000.740299
12:56 ET4000.7405
12:57 ET66930.739
12:59 ET21000.739
01:01 ET6000.740315
01:08 ET1000.737
01:14 ET14000.737
01:24 ET1000.737
01:26 ET1000.737
01:35 ET1000.737
01:48 ET3680.737
01:50 ET21000.737
01:51 ET23000.737
01:53 ET2600.7385
02:15 ET1000.735
02:36 ET1000.735
02:45 ET13820.73924
02:56 ET27500.735
02:58 ET6000.7342
03:07 ET1000.735
03:14 ET47430.7388
03:18 ET17470.7389
03:23 ET10000.74
03:25 ET1000.74
03:30 ET4000.74
03:41 ET2000.7401
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBOLT
Bolt Biotherapeutics Inc
28.6M
-0.4x
---
United StatesCIPI
Correlate Energy Corp
20.1M
-1.7x
---
United StatesATRA
Atara Biotherapeutics Inc
40.4M
-0.2x
---
United StatesAWH
Aspira Women's Health Inc
20.5M
-1.2x
---
United StatesVBIV
VBI Vaccines Inc
17.2M
-0.1x
---
United StatesEVGN
Evogene Ltd
32.0M
-1.4x
---
As of 2024-06-24

Company Information

Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The Company's pipeline candidates are built on its expertise in myeloid biology and cancer drug development. Its pipeline includes trastuzumab imbotolimod (formerly BDC-1001), a human epidermal growth factor receptor 2 - targeting Boltbody Immune-Stimulating Antibody Conjugate (ISAC), BDC-3042, a myeloid-modulating antibody, and multiple Boltbody ISAC collaboration programs. Trastuzumab imbotolimod is in Phase 2 clinical. BDC-3042, an agonist antibody targeting Dectin-2, is in a Phase 1 dose-escalation trial. In preclinical development, BDC-3042 demonstrated the ability to convert tumor-supportive macrophages to tumor-destructive macrophages. It developed a lead agonist antibody that binds to Dectin-2 and activates human tumor-associated macrophages. It is developing multiple Boltbody ISACs in strategic collaborations with biopharmaceutical companies.

Contact Information

Headquarters
900 Chesapeake DriveREDWOOD CITY, CA, United States 94063
Phone
650-665-9295
Fax
302-531-3150

Executives

President, Chief Executive Officer, Chief Financial Officer, Director
William Quinn
Chief Operating Officer
Grant Yonehiro
Lead Independent Director
James Healy
Independent Director
Laura Berner
Independent Director
Kathleen Laporte

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$28.6M
Revenue (TTM)
$11.3M
Shares Outstanding
38.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.93
EPS
$-1.66
Book Value
$2.96
P/E Ratio
-0.4x
Price/Sales (TTM)
2.5
Price/Cash Flow (TTM)
---
Operating Margin
-619.90%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.